| mRNA |
PD-0332991 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
5e-05 |
| mRNA |
TW 37 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0001 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0001 |
| mRNA |
Bleomycin |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0002 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0004 |
| mRNA |
NVP-ADW742 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0007 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.0008 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0009 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
| mRNA |
BMS-754807 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |